Biofilms and intracellular survival tremendously help Helicobacter pylori (H. pylori) escape
from antibacterial agents attacking, therefore issuing extreme challenges to clinical …

Helicobacter pylori (H. pylori) is a recalcitrant pathogen, which can cause gastric disorders.
During the past decades, polypharmacy‐based regimens, such as triple and quadruple …

Inspired by the natural pathogen–host interactions and adhesion, this study reports on the
development of a novel targeted nanotherapeutic for the treatment of Helicobacter pylori …

Helicobacter pylori (H. pylori) is the main cause of gastric adenocarcinoma. However, the
traditional antibiotic treatment of H. pylori is limited due to increased antibiotic resistance …

Helicobacter pylori is a significant human pathogen that recognizes specific carbohydrate
receptors, such as the fucose receptor, and produces the vacuolating cytotoxin, which …

We present a bioinspired design strategy to engineer bacteria-targeting and membrane-
disruptive nanoparticles for the effective antibiotic therapy of Helicobacter pylori (H. pylori) …

Aim: The aim of this work was to develop fucose-conjugated nanoparticles and control the
release of berberine, and demonstrate that these particles come into contact with …

The resistance of Helicobacter pylori (H. pylori) to conventional antibiotic treatments
becomes prevalent recently. The biofilm formation was found to be highly correlated with the …

Aim: This study aims to validate the anti-Helicobacter pylori efficacy of amoxicillin-loaded
nanoparticles and nanogels with pH-responsive and site-specific drug release properties …

Helicobacter pylori (H. pylori) infection is considered to be the main cause of most digestive
diseases, such as chronic active gastritis, gastroduodenal ulcers, or even gastric cancer …